Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737–Mediated Cell Death in Malignant Human Glioma Cell Lines

Por Jane, Esther P., Premkumar, Daniel R., Cavaleri, Jonathon M., Sutera, Philip A., Rajasekar, Thatchana, Pollack, Ian F.
Publicado no J Pharmacol Exp Ther (2016)